Diabetes, Hypertension, and Cardiovascular Diseases: New Insights, Risk Factors, and Drug Therapies
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 10 January 2026 | Viewed by 151
Special Issue Editors
Interests: heart failure; advanced heart failure; cardiopulmonary exercise test; rehabilitation; cardiametabolic medicine; cardiovascular imaging
Special Issues, Collections and Topics in MDPI journals
Interests: atherosclerosis; diabetes; angiogenesis; microRNA; endothelium
Special Issue Information
Dear Colleagues,
Although the strong association between diabetes, hypertension, and cardiovascular disease (CVD) has been well established and extensively studied over recent decades, emerging pathophysiological mechanisms and novel biomarkers and risk factors continue to shed new light on these links. These advancements are enhancing the development of innovative diagnostic tools and targeted therapies. In the era of big data and artificial intelligence, evidence-based medicine is evolving into precision medicine, offering more effective and individualized approaches with improved safety profiles. Given that CVD remains the leading cause of morbidity and mortality worldwide, the timely integration of precision medicine into cardiovascular care is imperative. This Special Issue will highlight recent breakthroughs in our understanding of these interconnected conditions and explore cutting-edge innovations in diagnostics and therapeutic strategies.
We welcome original research articles, review articles, and systematic reviews or meta-analyses that address the following topics:
- Novel insights into the pathophysiological mechanisms linking diabetes, hypertension, and cardiovascular disease;
- Emerging risk factors and biomarkers influencing diagnostic strategies, disease progression, and clinical outcomes;
- Recent advances in pharmacological and non-pharmacological innovative treatments;
- The role of precision medicine and artificial intelligence in diagnostic procedures and therapeutic decisions.
We encourage submissions from researchers across diverse scientific fields, including cardiovascular medicine, interventional cardiology, endocrinology, nephrology, and internal medicine.
We look forward to receiving your valuable contributions. Please feel free to reach out if you have any questions.
Dr. Christina Chrysohoou
Dr. Panagiotis Theofilis
Guest Editors
Dr. Emmanouil Mantzouranis
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- hypertension
- cardiovascular disease
- cardiovascular risk factors
- novel drug therapies
- novel therapies
- coronary artery disease
- heart failure
- precision medicine
- artificial intelligence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
